샘플 요청 목록

 카트 문의
시장보고서
상품코드
1420309

세계 액체 색전물질 시장 - 업계 분석, 규모, 점유율, 성장 및 동향 예측(2031년) : 제품별, 적응증별, 최종 사용자별, 지역별

Liquid Embolic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 280 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 액체 색전물질 시장 규모는 2024년에 2억 7,000만 달러에 달할 것으로 보이며, 2031년까지 약 5억 8,050만 달러에 달할 것으로 예측되고 있으며, 연평균 성장률(CAGR)은 8.9% 되어 현저한 성장 궤도를 잡는 것으로 보입니다.

액체 색전 바이알은 현재 세계 시장에서 82.7%라는 큰 점유율을 차지하고 있습니다. 액상 색전 제품은 동정맥 기형의 치료에 사용되어 성공을 거두고 있지만, 동맥류 치료에의 적용은 주로 모혈관으로의 액체의 전이를 막는 우려로부터 일부 환자에게 한정 남아 있습니다.

세계의 액체 색전물질 시장은 지난 5년간 4.2%의 연평균 복합 성장률(CAGR)로 확대되었습니다. 색전술은 하나 이상의 혈관과 비정상적인 혈관 채널을 차단하는 데 사용되는 낮은 침습 치료입니다. 다양한 색전제가 카테터를 통해 혈관으로 도입되어 특정 부위로의 혈류를 억제합니다. n-부틸시아노아크릴레이트(NBCA) 및 에틸비닐알코올 공중합체와 같은 액체 색전물질는 색전 요법에서 중요한 역할을 합니다.

액체 색전물질 수요는 향후 10년간 상당한 비율로 급증할 것으로 예상되며 CAGR은 약 8.9%로 예측되고 있습니다. 이러한 성장은 2024년부터 2031년까지 3억 3,340만 달러의 기회 증가를 가져올 것으로 예상됩니다. 액체 색전 바이알은 액체 프리필드 주사제와 비교하여 예측 기간 동안 높은 수요를 유지할 것으로 예상됩니다.

종양 색전술은 전 세계적으로 종양 발생률이 증가하고 있기 때문에 액체 색전물질 제조업체에게 큰 기회가 되었습니다. 이 낮은 침습 수술은 종양으로의 혈액 공급을 차단하거나 종양을 죽이는 치료제를 종양에 직접 투여합니다.

본 보고서에서는 세계의 액체 색전물질 시장에 대해 조사했으며,, 시장 개요와 함께 제품별, 적응증별, 최종 사용자별, 지역별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아의 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 생산고와 무역통계(2018-2023년)

제4장 가격 분석(2018-2023년)

제5장 세계의 액체 색전물질 시장 전망(2018-2031년)

  • 세계의 액체 색전물질 시장 전망, 제품별 금액(100만 달러) 및 수량(개)(2018-2031년)
  • 세계의 액체 색전물질 시장 전망, 적응증별 금액(100만 달러) 및 수량(개)(2018-2031년)
  • 세계의 액체 색전물질 시장 전망, 최종 사용자별 금액(100만 달러) 및 수량(개)(2018-2031년)
  • 세계의 액체 색전물질 시장 전망, 지역별 금액(100만 달러) 및 수량(개)(2018-2031년)

제6장 북미의 액체 색전물질 시장 전망(2018-2031년)

제7장 유럽의 액체 색전물질 시장 전망(2018-2031년)

제8장 아시아태평양의 액체 색전물질 시장 전망(2018-2031년)

제9장 라틴아메리카의 액체 색전물질 시장 전망(2018-2031년)

제10장 중동 및 아프리카의 액체 색전물질 시장 전망(2018-2031년)

제11장 경쟁 구도

  • 최종 사용자별 및 적응증별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁 대시보드
  • 기업 프로파일
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Johnson & Johnson
    • Wright Medical Group NV
    • Microvention Inc.
    • Terumo Corporation
    • Guerbet
    • Emboflu
    • Boston Medical Corporation

제12장 부록

JHS 24.02.13

The global liquid embolic market, valued at US$ 270 million in 2024, is set to experience a significant growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 8.9% to reach a market valuation of approximately US$ 580.5 million by 2031, according to a recent market analysis by Fairfield Market.

Liquid Embolic Vials Dominate Market Share

Liquid embolic vials currently hold a substantial share of 82.7% in the global market. While liquid embolic products have been successfully used in the treatment of arteriovenous malformations, their application in aneurysm treatment remains limited to a select group of patients, primarily due to concerns about preventing the migration of the liquid to the parent vessel.

Demand Analysis and Growth Prospects

The global market for liquid embolics has expanded at a CAGR of 4.2% over the past five years. Embolization is a minimally invasive procedure used to block one or more blood vessels or abnormal vascular channels. Various embolic agents are introduced through catheters into blood vessels to inhibit blood flow to specific areas, with liquid embolic agents such as n-Butyl Cyanoacrylate (NBCA) and ethyl vinyl alcohol copolymers playing a vital role in therapeutic embolization.

The demand for liquid embolic products is expected to surge at a substantial rate over the next decade, with a projected CAGR of around 8.9%. This growth is anticipated to bring about an incremental opportunity of US$ 333.4 million from 2024 to 2031. Liquid embolic vials are expected to remain in high demand throughout the forecast period compared to liquid prefilled injectables.

Key Opportunities for Liquid Embolic Product Manufacturers

Tumor embolization presents a significant opportunity for liquid embolic product manufacturers, given the increasing incidence of tumors worldwide. This minimally invasive procedure involves shutting down the blood supply to tumors or delivering tumor-killing therapy directly to them.

Companies developing liquid embolic agents could expand their market share by pursuing regulatory approvals for indications beyond neuro interventional, tapping into the rising prevalence of cancer. Additionally, the growing demand for neurovascular embolization devices, driven by an increasing prevalence of cerebral aneurysms, offers further market growth prospects.

Advancements in research and development also provide opportunities for both emerging and established liquid embolic product suppliers to establish a strong presence in the market.

Factors Restraining Demand for Liquid Embolic Systems

While the demand for liquid embolic products is on the rise, certain challenges must be addressed. These include issues such as balloon deflation, catheter entrapment, and difficulties in deploying the device to the targeted lesion. Moreover, the high risk associated with liquid embolic procedures, including the potential of targeting the wrong blood vessels during surgical procedures, is a concern.

Additionally, limited liquid embolic agent manufacturers face intense competition from alternative transcatheter embolization devices, which could potentially restrain the growth of the liquid embolic systems market.

Country-wise Insights

The U.S.: Largest Regional Liquid Embolic Market

The United States dominates the North America liquid embolic market, with a substantial market share. This dominance is driven by factors such as unhealthy lifestyle habits, including junk food consumption, smoking, and alcohol use, as well as a sedentary lifestyle. These habits have led to a higher prevalence of chronic diseases like high blood pressure, migraines, and bAVM, increasing the demand for liquid embolic products and agents in the U.S. Moreover, lifestyle changes have been associated with a significant percentage of cancer cases in the country, further contributing to the demand for such products.

Germany: A Lucrative Market in Europe

Germany is expected to be a prominent player in the European market for liquid embolics. This is primarily due to the substantial number of clinical trials and research conducted in the country, particularly in the field of cancer research. Germany boasts a significant number of research ethics committees, with active government involvement in healthcare and cancer-related research and innovation. This environment presents lucrative opportunities for suppliers of liquid embolic products to grow in the market.

South Korea: An Emerging Market

South Korea is an emerging market in the East Asia liquid embolic market. The country is witnessing substantial growth in this sector, mainly due to the increasing prevalence of cardiovascular diseases. For instance, coronary heart disease-related deaths in South Korea have been a significant concern. This growth in cardiovascular issues has led to a rising demand for liquid embolic products and is expected to continue to expand in the coming years.

Competitive Analysis

Leading liquid embolic product providers are adopting growth strategies such as new product launches, approvals, agreements, collaborations, and partnerships. These strategies are helping key stakeholders expand their geographic footprint and strengthen their existing product portfolios.

Key Companies Profiled:

  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Johnson & Johnson
  • Microvention Inc.
  • Terumo Corporation
  • Guerbet
  • Emboflu

Key Segments Covered in Liquid Embolic Industry Research

Liquid Embolic Market by Product

  • Liquid Embolic Vials
  • Liquid Embolic Prefilled Injectables

Liquid Embolic Market by Indication

  • Brain Arterio-Venous Malformations (bAVM)
  • Tumor Embolization
  • Radiology
  • Cardiology

Liquid Embolic Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Speciality Centres

Liquid Embolic Market by Region

  • North America Liquid Embolic Market
  • Latin America Liquid Embolic Market
  • Europe Liquid Embolic Market
  • East Asia Liquid Embolic Market
  • South Asia Liquid Embolic Market
  • Oceania Liquid Embolic Market
  • Middle East & Africa (MEA) Liquid Embolic Market

Table of Contents

1. Executive Summary

  • 1.1. Global Liquid Embolic Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Liquid Embolic Production Output, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Liquid Embolic Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Liquid Embolic Market Outlook, 2018 - 2031

  • 5.1. Global Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Liquid Embolic Vials
      • 5.1.1.2. Liquid Embolic Prefilled Injectables
  • 5.2. Global Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 5.2.1.2. Tumor Embolization
      • 5.2.1.3. Radiology
      • 5.2.1.4. Cardiology
  • 5.3. Global Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Ambulatory Surgical Centers
      • 5.3.1.3. Independent Speciality Centres
  • 5.4. Global Liquid Embolic Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Liquid Embolic Market Outlook, 2018 - 2031

  • 6.1. North America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Liquid Embolic Vials
      • 6.1.1.2. Liquid Embolic Prefilled Injectables
  • 6.2. North America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 6.2.1.2. Tumor Embolization
      • 6.2.1.3. Radiology
      • 6.2.1.4. Cardiology
  • 6.3. North America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Ambulatory Surgical Centers
      • 6.3.1.3. Independent Speciality Centres
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Liquid Embolic Market Outlook, 2018 - 2031

  • 7.1. Europe Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Liquid Embolic Vials
      • 7.1.1.2. Liquid Embolic Prefilled Injectables
  • 7.2. Europe Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 7.2.1.2. Tumor Embolization
      • 7.2.1.3. Radiology
      • 7.2.1.4. Cardiology
  • 7.3. Europe Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Ambulatory Surgical Centers
      • 7.3.1.3. Independent Speciality Centres
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Liquid Embolic Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Liquid Embolic Vials
      • 8.1.1.2. Liquid Embolic Prefilled Injectables
  • 8.2. Asia Pacific Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 8.2.1.2. Tumor Embolization
      • 8.2.1.3. Radiology
      • 8.2.1.4. Cardiology
  • 8.3. Asia Pacific Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Ambulatory Surgical Centers
      • 8.3.1.3. Independent Speciality Centres
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Liquid Embolic Market Outlook, 2018 - 2031

  • 9.1. Latin America Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Liquid Embolic Vials
      • 9.1.1.2. Liquid Embolic Prefilled Injectables
  • 9.2. Latin America Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 9.2.1.2. Tumor Embolization
      • 9.2.1.3. Radiology
      • 9.2.1.4. Cardiology
  • 9.3. Latin America Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Ambulatory Surgical Centers
      • 9.3.1.3. Independent Speciality Centres
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Liquid Embolic Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Liquid Embolic Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Liquid Embolic Vials
      • 10.1.1.2. Liquid Embolic Prefilled Injectables
  • 10.2. Middle East & Africa Liquid Embolic Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Brain Arterio-Venous Malformations (bAVM)
      • 10.2.1.2. Tumor Embolization
      • 10.2.1.3. Radiology
      • 10.2.1.4. Cardiology
  • 10.3. Middle East & Africa Liquid Embolic Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Ambulatory Surgical Centers
      • 10.3.1.3. Independent Speciality Centres
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Liquid Embolic Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Liquid Embolic Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Liquid Embolic Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Liquid Embolic Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Indication Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Medtronic
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Meril Life Sciences Pvt. Ltd.
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Johnson & Johnson
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Wright Medical Group N.V.
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Microvention Inc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Terumo Corporation
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Guerbet
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Emboflu
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Boston Medical Corporation
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제